Insufficient data to provide a comprehensive gene function summary. The provided PubMed abstract (1) concerns macular pigments (lutein and zeaxanthin) and is unrelated to ABO blood group antigen synthesis. Based solely on the abstract provided, no support can be cited for ABO gene function claims. However, the NCBI summary and UniProt annotations indicate ABO encodes a glycosyltransferase that catalyzes alpha-1,3 linkage of GalNAc or Gal residues to terminal galactose of H antigens, generating A and B blood group determinants. The enzyme localizes to Golgi membranes and cisternae. ABO variants determine blood type phenotypes critical for transfusion compatibility and have been associated with disease susceptibility in population studies. To properly document ABO function, mechanism, disease relevance, and clinical significance with PubMed citations, relevant abstracts specifically addressing ABO glycosyltransferase activity, blood group antigen synthesis, genetic variants, or clinical associations would be required.